The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Nkarta Names Nadir Mahmood As President and David R. Shook, M.D., As Chief Medical Officer, Head of Research & Development
PUBLIC · NKTXJul 16, 2024•almost 2 years ago
Position
Director of Research and Development
Company
Nkarta
David R. Shook
San FranciscoBiotechnology
Description
Nkarta, Inc. announced the appointment of Nadir Mahmood, Ph.D., as President and David R. Shook, M.D., as Chief Medical Officer, Head of Research & Development
Company Information
Company
Nkarta
Location
San Francisco, California, United States
About
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.